Seller record · Telehealth service
Eve
Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the home page, the terms or the safety page. 1 more criterion also fails; see the table below.
At a glance
EveTelehealth service
- Price
- Not printed before a consultation or sign-up
- Sells
- GLP-1 therapy, tirzepatide, Mounjaro, and 2 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth platform that connects patients with an outside physician group for GLP-1 weight loss treatment, including compounded medication and Mounjaro, Ozempic and Wegovy, and says the patient pays nothing unless a physician approves treatment. It also lists longevity and hair health lines.
Operating entity Eve Health, Inc.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Eve's website; Eve's term of uses page |
| S2 | Prescription gating | PASS | Eve's website |
| S3 | Pharmacy identification | PASS | Eve's term of uses page |
| S4 | Compounding disclosure | PASS | Eve's website; Eve's important safety information page |
| S5 | Analytical documentation | FAIL | Eve's website; Eve's term of uses page; Eve's important safety information page |
| S6 | Business address | PASS | Eve's privacy policy |
| S7 | Price disclosure | FAIL | Eve's website; Eve's term of uses page; Eve's important safety information page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: GLP-1 therapy, tirzepatide, Mounjaro, Ozempic, Wegovy.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.